Trauma & major bleeding

Lateral Versus Midline: A Retrospective Review of Paracentesis Site Location and Risk of Hemorrhagic Complication

Crit Care MedPublished Retrospective cohort study

Authors' conclusion

These data suggest midline paracentesis may reduce the risk of post-procedural hemorrhage among patients undergoing paracentesis.

Study context

Population
Patients undergoing ultrasound-guided percutaneous abdominal paracentesis, University of Chicago, January 1, 2011–January 1, 2020procedures with location data
Participants
4,513 patients
Exposure
Midline vs lateral percutaneous catheter placement for paracentesis
  • Midlinen = 230
  • Lateraln = 4,283reference
Outcome
Post-paracentesis clinically significant hemorrhage (CT evidence of hemorrhage at procedural site requiring blood transfusion, angiographic intervention, or resulting in death)
Follow-up
Within 7 days of paracentesis
Methodological detailsretrospective chart review, ultrasound-guided
  • Retrospective chart review
  • Ultrasound-guided

Main finding

As reported in the abstract

Clinically significant hemorrhage

Midline

0

events

Lateral

60

events

P = 0.03

Observational data: associations, not effects.

Further findings

Mean

OutcomeMidlineLateralP value
MELD 3.0 score (patients with cirrhosis)Mann-Whitney U test; standardized effect size 0.07125 (SD 8.13)22 (SD 8.46)P ≤ 0.001
  • MELD 3.0 score (patients with cirrhosis): Lateral n = 2086; Midline n = 118

Patient variables associated with hemorrhage (logistic regression)

Only serum bilirubin nearly approached significance
P = 0.07
No baseline variable had an odds ratio that did not cross 1.0

Original publication

Lateral Versus Midline: A Retrospective Review of Paracentesis Site Location and Risk of Hemorrhagic Complication. Crit Care Med. Published 26 September 2025. doi:10.1097/ccm.0000000000006883

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.